Farook Al‐Azzawi

No ORCID on file · 8 papers in corpus · active 1996-2006

Study types

  • article 8

Condition tags

  • endometriosis 1
  • adenomyosis 1
article 2006
Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell
·doi:10.1093/molehr/gal014

Matrix metalloproteinases (MMP) are considered to be of critical importance in the initiation of menstruation where MMP protein levels are reciprocally modulated by the actions of the gonadal steroid hormones, estradiol (E(2)) and progester…

article 2005
Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie ·doi:10.1016/j.etp.2004.10.001
article 2001
Changes in serum vascular endothelial growth factor following initiation of estrogen replacement after hysterectomy and oophorectomy
·doi:10.1080/j.1600-0412.2001.080006554.x
article 2001
Changes in serum vascular endothelial growth factor following initiation of estrogen replacement after hysterectomy and oophorectomy
·doi:10.1034/j.1600-0412.2001.080006554.x

BACKGROUND: Vascular endothelial growth factor has been shown to play an important role in preservation and restoration of endothelial integrity. Similar effects on endothelial function have been described with estrogen replacement. This po…

article 2000
The effect of hormone replacement therapy on the immunoreactive concentrations in the endometrium of oestrogen and progesterone receptor, heat shock protein 27, and human β-lactoglobulin
·doi:10.1093/humrep/15.1.36

We determined the expression of oestrogen receptor (ER), progesterone receptor (PR), heat shock protein 27 (HSP27) and human beta-lactoglobulin in the endometrium under hormone replacement therapy (HRT). The immunohistochemical expression d…

article 2000
The effect of submucous fibroids on the dose‐dependent modulation of uterine bleeding by trimegestone in postmenopausal women treated with hormone replacement therapy
·doi:10.1111/j.1471-0528.2000.tb13227.x

OBJECTIVE: To assess the value of identifying endometrial structural abnormalities at baseline hysteroscopy in predicting the pattern of bleeding in postmenopausal women treated with hormone replacement therapy. DESIGN: A randomised, double…

article 1998
Endometrial responses to hormone replacement therapy: histological features compared with those of late luteal phase endometrium
·doi:10.1093/humrep/13.6.1674

We evaluated the histological features of the endometrium in relation to the bleeding pattern in a group of women receiving oral cyclical combined hormone replacement therapy (HRT), and compared the histological features with those of lutei…

article 1996
Immunohistochemical and hysteroscopic assessment of postmenopausal women with uterine bleeding whilst taking Tibolone
European Journal of Obstetrics & Gynecology and Reproductive Biology ·doi:10.1016/0301-2115(95)02378-x